Nephros
NEPH
17 hedge funds and large institutions have $9.8M invested in Nephros in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
34.21% more ownership
Funds ownership: 16.64% → 50.85% (+34%)
0% more funds holding
Funds holding: 17 → 17 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
34% less capital invested
Capital invested by funds: $14.9M → $9.8M (-$5.12M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
| 2 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$48.9K |
| 3 |
BlackRock
New York
|
+$2.99K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$562 |
| 5 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
+$453 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samjo Capital
New York
|
-$913K |
| 2 |
CPA
Cowen Prime Advisors
New York
|
-$198K |
| 3 |
Millennium Management
New York
|
-$118K |
| 4 |
Morgan Stanley
New York
|
-$53.7K |
| 5 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
-$31K |
NEPH Hedge Fund Activity: Q4 2021 in Review
17 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q4 2021, worth a combined $9.8M — down 34% from $14.9M a quarter earlier.
Fund positioning in NEPH was balanced in Q4 2021: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $156K. The largest seller was Samjo Capital, cutting an estimated $913K.
- 17 institutional investors held Nephros (NEPH) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $9.8M of Nephros stock for Q4 2021, down 34% quarter-over-quarter.
- 2 funds opened new Nephros positions in Q4 2021 and 2 closed out, a net change of 0 holders.
- The largest Nephros buyer in Q4 2021 was Vanguard Group, an estimated $156K added.
- The largest Nephros seller in Q4 2021 was Samjo Capital, an estimated $913K sold.
Based on aggregated 13F filings for Q4 2021.